Redmile Group, LLC - AYALA PHARMACEUTICALS INC ownership

AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 8 filers reported holding AYALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of AYALA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$372,000
-79.2%
341,030
-24.2%
0.01%
-75.0%
Q1 2022$1,790,000
-68.5%
449,731
-32.7%
0.06%
-56.6%
Q4 2021$5,683,000
-25.0%
667,8160.0%0.13%
-2.3%
Q3 2021$7,573,000
+11.3%
667,8160.0%0.13%
+30.7%
Q2 2021$6,805,000
-6.6%
667,8160.0%0.10%
-1.9%
Q1 2021$7,286,000
-4.2%
667,8160.0%0.10%
+12.0%
Q4 2020$7,606,000
-3.1%
667,816
+0.2%
0.09%
-36.1%
Q3 2020$7,853,000
+17.4%
666,6660.0%0.14%
+17.1%
Q2 2020$6,687,000666,6660.12%
Other shareholders
AYALA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Harel Insurance Investments & Financial Services Ltd. 2,153,273$8620.02%
Psagot Value Holdings Ltd. / (Israel) 36,232$140.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 56,900$23,9440.00%
Ameliora Wealth Management Ltd. 750$3160.00%
Renaissance Technologies 53,600$210.00%
Avantax Planning Partners, Inc. 10,000$4,0010.00%
UBS Group AG 1,010$4040.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,596$40.00%
MORGAN STANLEY 13,931$5,5740.00%
View complete list of AYALA PHARMACEUTICALS INC shareholders